dr. sharma on pd-l1 as biomarker for immunotherapy in bladder cancer
Published 8 years ago • 667 plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
1:32
utility of pd-l1 as a biomarker in bladder cancer
-
2:41
should pd-l1 be used as a biomarker for immunotherapy in bladder cancer?
-
1:47
dr. siefker-radtke on pd-l1 as a biomarker in bladder cancer
-
1:41
dr. goldberg on pd-l1 as a biomarker in lung cancer
-
2:26
pd-l1 immunotherapy in bladder cancer
-
1:42
dr. gandara discusses pd-l1 as a biomarker in lung cancer
-
1:33:59
revisiting pd-l1 as an immunotherapy biomarker across the cancer spectrum
-
0:54
dr. o’donnell on challenges with pd-l1 testing in bladder cancer
-
7:55
pd-l1 expression in bladder cancer
-
3:50
the role of pd-l1: is it accurate enough as a biomarker for immunotherapy response?
-
1:16
dr. suzanne l. topalian on pd-l1 and emerging biomarkers for immunotherapy
-
1:21
dr. o’donnell on pd-l1 testing in bladder cancer
-
3:36
anti-pd-l1 immunotherapy with mpdl3280a in metastatic bladder cancer
-
1:03
dr. costa on biomarkers beyond pd-l1 for immunotherapy in nsclc
-
1:46
dr. iyer on advice for physicians using immunotherapy in bladder cancer
-
4:47
pd-l1 biomarker testing
-
0:59
dr. inman on biomarkers for immunotherapy in bladder cancer
-
5:06
should pd-l1 be used as a biomarker for immunotherapy in lung cancer?
-
1:07
exploring the role of biomarkers in patient selection for immunotherapy in bladder cancer